The American Academy of Otolaryngology-Head and Neck Surgery endorses the concept of the use of AzBio Sentence (with or without background noise) and Consonant-Noise-Consonant (CNC) word tests as minimal reporting requirements for results of cochlear implantation in adults. The minimum speech test battery (MSTB-3) shall apply, at present, to adult patients only and is not required with respect to patients who have already been implanted.
Originally Published: February 10, 1997
Reviewed: February 2026
References:
- Dunn CC, Zwolan TA, Balkany TJ, Strader HL, Biever A, Gifford RH, Hall MW, Holcomb MA, Hill H, King ER, Larky J, Presley R, Reed M, Shapiro WH, Sydlowski SA, Wolfe J. A Consensus to Revise the Minimum Speech Test Battery-Version 3. Am J Audiol. 2024 Sep 3;33(3):624-647. doi: 10.1044/2024_AJA-24-00008. Epub 2024 Jul 9. PMID: 38980836.
Important Disclaimer Notice (Updated 7/31/14)
Position statements are approved by the American Academy of Otolaryngology—Head and Neck Surgery or Foundation (AAO-HNS/F) Boards of Directors and are typically generated from AAO-HNS/F committees. Once approved by the Academy or Foundation Board of Directors, they become official position statements and are added to the existing position statement library. In no sense do they represent a standard of care. The applicability of position statements, as guidance for a procedure, must be determined by the responsible physician in light of all the circumstances presented by the individual patient. Adherence to these clinical position statements will not ensure successful treatment in every situation. As with all AAO-HNS/F guidance, this position statement should not be deemed inclusive of all proper treatment decisions or methods of care, nor exclusive of other treatment decisions or methods of care reasonably directed to obtaining the same results. Position statements are not intended to and should not be treated as legal, medical, or business advice.
